MERRIMACK PHARMACEUTICALS INC Deferred Revenue (Non-Current)
MERRIMACK PHARMACEUTICALS INC had Deferred Revenue (Non-Current) of $25.67 million as of 2016-12-31, per its 10-K filed 2017-03-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:DeferredRevenueNoncurrent · last filed 2017-03-01
- 2016-12-31: Deferred Revenue, Noncurrent $25.67M.
- 2016-09-30: Deferred Revenue, Noncurrent $36.33M.
- 2016-06-30: Deferred Revenue, Noncurrent $39.90M.
- 2016-03-31: Deferred Revenue, Noncurrent $47.10M.
| Period end | Deferred Revenue, Noncurrent |
|---|---|
| 2016-12-31 | $25.67M 10-K · filed 2017-03-01 |
| 2016-09-30 | $36.33M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $39.90M 10-Q · filed 2016-08-04 |
| 2016-03-31 | $47.10M 10-Q · filed 2016-05-02 |
| 2015-12-31 | $51.20M 10-K · filed 2017-03-01 |
| 2015-09-30 | $13.96M 10-Q · filed 2015-11-09 |
| 2015-06-30 | $9.11M 10-Q · filed 2015-08-10 |
| 2015-03-31 | $23.23M 10-Q · filed 2015-05-07 |
| 2014-12-31 | $35.68M 10-K · filed 2016-02-26 |
| 2014-09-30 | $56.26M 10-Q · filed 2014-11-10 |
| 2014-06-30 | $3.02M 10-Q · filed 2014-08-11 |
| 2014-03-31 | $64.11M 10-Q · filed 2014-05-06 |
| 2013-12-31 | $66.14M 10-K · filed 2015-02-27 |
| 2013-09-30 | $66.39M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $68.72M 10-Q · filed 2013-08-08 |
| 2013-03-31 | $68.51M 10-Q · filed 2013-05-13 |
| 2012-12-31 | $71.11M 10-K · filed 2014-03-04 |
| 2012-09-30 | $74.98M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $77.74M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $80.86M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $78.03M 10-K · filed 2013-03-20 |